Contrast enhancement with GD-EOB-DTPA in MR imaging of hepatocellular carcinoma in mice: A comparison with superparamagnetic iron oxide
Authors:
- Reiko YamamotoRYReiko Yamamoto
- Bernhard Fritz-ZierothBFBernhard Fritz-Zieroth
- Tsuyoshi YamanakaTYTsuyoshi Yamanaka
- Masaya TakahashiMTMasaya Takahashi
- Tomoaki MiyazawaTMTomoaki Miyazawa
- Masaharu TatsutaMTMasaharu Tatsuta
- Nobuyuki TeradaNTNobuyuki Terada
- Naohiro HosomiNHNaohiro Hosomi
- Etsuo InoueEIEtsuo Inoue
- Chikazumi KurodaCKChikazumi Kuroda
- 1 May 1996
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 6 (3) , 472-477
Abstract
The purpose of this study was to evaluate the ability of the new liver-specific magnetic resonance contrast agent gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid (Gd-EOB-DTPA) to detect hepatocellular carcinoma (HCC). Seventeen mice with 66 chemically induced HCCs underwent magnetic resonance imaging with both Gd-EOB-DTPA (30 mumol/kg) and superparamagnetic iron oxide (SPIO; 10 mumol/kg). After enhancement, lesion-to-liver contrast-to-noise ratios (CNRs) of 47 detected HCCs increased negatively from 3.7 +/- 10.7 (mean +/- SD) to -55.1 +/- 25.8 with Gd-EOB-DTPA (P < .001) and increased positively from 10.4 +/- 10.4 to 26.1 +/- 16.3 with SPIO (P < .001). The improvement of CNR after administration of SPIO was less in smaller lesions (< 4 mm), whereas that after administration of Gd-EOB-DTPA was independent of lesion size. However, Gd-EOB-DTPA positively enhanced four HCCs (8.5%), both highly differentiated (grade 1) and moderately differentiated (grade 2). Gd-EOB-DTPA allows the conspicuous detection of small HCCs; however, moderately differentiated HCCs occasionally may be positively enhanced.Keywords
This publication has 28 references indexed in Scilit:
- Contrast‐enhanced MR imaging of liver and spleen: First experience in humans with a new superparamagnetic iron oxideJournal of Magnetic Resonance Imaging, 1994
- Superparamagnetic iron oxide: Detection of focal liver lesions at high‐field‐strength MR imagingJournal of Magnetic Resonance Imaging, 1994
- Prolonged positive contrast enhancement with Gd‐EOB‐DTPA in experimental liver tumors: Potential value in tissue characterizationJournal of Magnetic Resonance Imaging, 1994
- Mn‐DPDP–enhanced MR imaging of malignant liver lesions: Efficacy and safety in 20 patientsJournal of Magnetic Resonance Imaging, 1993
- Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: A correlation study of MR imaging, microangiography, and histologyMagnetic Resonance Imaging, 1993
- Roles of ovaries and testes in hepatocellular tumorigenesis induced in mice by 3′‐methyl‐4‐dimethylaminoazobenzeneInternational Journal of Cancer, 1991
- Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.American Journal of Roentgenology, 1990
- Dynamic MR imaging of the liver with Gd-DTPA: initial clinical resultsAmerican Journal of Roentgenology, 1989
- Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 TAmerican Journal of Roentgenology, 1989
- MR Imaging of Hepatocellular CarcinomaJournal of Computer Assisted Tomography, 1986